Grifols, S.A. Competitors

GRFS 
$33.29
*  
0.48
1.46%
Get GRFS Alerts
*Delayed - data as of Apr. 1, 2015  -  Find a broker to begin trading GRFS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Grifols, S.A.

CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Abbott Laboratories
ABT: NYSE
$ 45.89 -0.44 ▼ 6,365,986 $ 46.37
$ 45.545
$ 47.88
$ 36.65
30.8 69,247,000,420
AbbVie Inc.
ABBV: NYSE
$ 57.10 -1.44 ▼ 14,889,356 $ 58.49
$ 56.33
$ 70.76
$ 45.50
52.39 90,911,536,600
ACADIA Pharmaceuticals Inc.
ACAD: NASDAQ-GS
$ 32.04 -0.55 ▼ 1,726,477 $ 32.68
$ 31.164
$ 46.48
$ 15.64
NE 3,209,510,880
Acasti Pharma, Inc.
ACST: NASDAQ-CM
$ .4714 -0.01 ▼ 40,579 $ .4725
$ .45
$ 1.22
$ .352
NE 49,903,347
AcelRx Pharmaceuticals, Inc.
ACRX: NASDAQ-GM
$ 3.92 0.06 ▲ 657,065 $ 3.94
$ 3.69
$ 12.35
$ 3.58
NE 172,480,000
Achaogen, Inc.
AKAO: NASDAQ-GM
$ 8 -1.76 ▼ 794,845 $ 8.79
$ 7.685
$ 17.44
$ 7.72
NE 142,064,000
Achillion Pharmaceuticals, Inc.
ACHN: NASDAQ-GS
$ 10.01 0.15 ▲ 2,897,865 $ 10.04
$ 9.56
$ 16.87
$ 2.45
NE 1,141,610,470
Actavis, Inc.
ACT: NYSE
$ 296.43 -1.19 ▼ 4,496,940 $ 299.77
$ 292.82
$ 317.72
$ 184.71
NE 78,925,080,360
Actinium Pharmaceuticals, Inc.
ATNM: AMEX
$ 2.51 0.04 ▲ 215,450 $ 2.66
$ 2.3951
$ 15
$ 2.40
NE 89,059,820
Acura Pharmaceuticals, Inc.
ACUR: NASDAQ-CM
$ .81 0.02 ▲ 186,320 $ .8491
$ .789
$ 1.5496
$ .41
NE 39,647,070
Adamas Pharmaceuticals, Inc.
ADMS: NASDAQ-GM
$ 17.47 -0.02 ▼ 50,948 $ 17.56
$ 16.99
$ 21.6299
$ 12.02
124.79 308,205,740
Adamis Pharmaceuticals Corporation
ADMP: NASDAQ-CM
$ 3.77 -0.17 ▼ 153,049 $ 4
$ 3.6901
$ 7.26
$ 2.62
NE 49,047,700
Advaxis, Inc.
ADXS: NASDAQ-CM
$ 15.49 1.05 ▲ 2,366,515 $ 15.55
$ 13.68
$ 14.99
$ 2.46
NE 366,261,050
Advaxis, Inc.
ADXSW: NASDAQ-CM
$ 11.44 1.04 ▲ 41,365 $ 11.45
$ 9.85
$ 12.90
$ .75
NE 51,949,040
Aegerion Pharmaceuticals, Inc.
AEGR: NASDAQ-GS
$ 26 -0.17 ▼ 648,179 $ 26.20
$ 25.35
$ 47.65
$ 19.10
NE 739,336,000
AEterna Zentaris Inc.
AEZS: NASDAQ-CM
$ .5387 0.00 ▲ 838,745 $ .555
$ .53
$ 1.54
$ .48
NE 48,783,056
Affimed N.V.
AFMD: NASDAQ-GM
$ 6.23 -0.07 ▼ 68,521 $ 6.49
$ 5.85
$ 9.16
$ 3.55
NE 138,517,820
Agile Therapeutics, Inc.
AGRX: NASDAQ-GM
$ 9.40 0.13 ▲ 26,037 $ 9.6177
$ 9.01
$ 12.55
$ 5.05
NE 174,774,200
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 95.76 1.46 ▲ 586,755 $ 95.86
$ 90.5833
$ 138.85
$ 31.42
NE 3,563,995,680
Akebia Therapeutics, Inc.
AKBA: NASDAQ-GM
$ 9.51 -1.60 ▼ 269,725 $ 11.12
$ 9.36
$ 31
$ 8.47
NE 193,442,910
Akorn, Inc.
AKRX: NASDAQ-GS
$ 47.40 -0.11 ▼ 1,377,484 $ 47.47
$ 45.59
$ 55.86
$ 20.52
143.64 5,111,189,400
Alcobra Ltd.
ADHD: NASDAQ-GM
$ 5.64 0.01 ▲ 235,075 $ 5.85
$ 5.50
$ 22.19
$ 3.12
NE 119,443,920
Alder BioPharmaceuticals, Inc.
ALDR: NASDAQ-GM
$ 27.52 -1.34 ▼ 400,289 $ 29.23
$ 26.89
$ 32.30
$ 9.50
NE 1,042,925,440
Aldeyra Therapeutics, Inc.
ALDX: NASDAQ-CM
$ 10.01 -0.17 ▼ 3,790 $ 10.25
$ 10.01
$ 13.50
$ 3
NE 68,968,900
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 169.50 -3.80 ▼ 2,864,913 $ 173.12
$ 167.45
$ 203.30
$ 136.37
51.99 34,264,255,500